Clinical Trials in Atlanta

Showing 17221-17240 of 19,805 trials

Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents

NCT00777790

This study was designed to evaluate the antibody response to a Menactra® booster dose in participants who previously received one dose of Menactra® or Menomune® as adolescents 3 years earlier in Study MTA02. Primary Objective: To evaluate the antibody responses to a booster dose of a tetravalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) in participants who had previously received Menactra® or Menomune® as adolescents in the MTA02 Study and antibody responses to a dose of Menactra® in naive adolescents.

MeningitisMeningococcemia

Sanofi Pasteur, a Sanofi Company241 participantsStarted Feb 2004

Atlanta, Georgia, United States • Marietta, Georgia, United States • Woburn, Massachusetts, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00002756

RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one chemotherapy drug and giving them as induction intensification may kill more cancer cells. PURPOSE: This phase II trial is studying how well induction intensification works in treating infants with newly diagnosed acute lymphocytic leukemia.

Leukemia

Children's Oncology Group221 participantsStarted Jun 1996

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +137 more locations

Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents

Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

Find Trials by Condition in Atlanta

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Insulin Infusion in the Hospital Wards

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients

Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma

Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321

Open, Prosp, Rand. Invest. Evaluating Pain With Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts

Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study

Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma

A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease

A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer

CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction